This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Cytokinetics, Inc., Astellas Pharma Gmbh. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 261 
3 out of 424 
Years Active: 2018-2022
Title: Hiroshi Kiyohara: Innovator in Pharmaceutical Compounds
Introduction
Hiroshi Kiyohara is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on tetrahydroisoquinoline derivatives. With a total of 4 patents to his name, Kiyohara's inventions are aimed at addressing various medical conditions.
Latest Patents
Kiyohara's latest patents focus on novel tetrahydroisoquinoline derivative compounds. These compounds are disclosed as potential active ingredients for pharmaceutical compositions. They are particularly useful for preventing or treating diseases that respond to the modulation of skeletal sarcomere contractility. The modulation can be achieved through the troponin complex of fast skeletal muscle sarcomeres, involving components such as fast skeletal myosin, actin, tropomyosin, troponin C, troponin I, and troponin T. The applications of these compounds include treating neuromuscular disorders, voluntary muscle disorders, CNS disorders characterized by muscle weakness and fatigue, systemic disorder-related muscle symptoms, and dysfunctions of pelvic floor and urethral/anal sphincter muscles.
Career Highlights
Throughout his career, Kiyohara has worked with prominent companies in the pharmaceutical industry. Notable among these are Cytokinetics, Inc. and Astellas Pharma GmbH. His work in these organizations has contributed to the advancement of medical treatments and innovations.
Collaborations
Kiyohara has collaborated with several professionals in his field, including Ippei Sato and Takashi Kamikubo. These collaborations have likely enhanced the development and application of his innovative compounds.
Conclusion
Hiroshi Kiyohara's contributions to the field of pharmaceuticals through his tetrahydroisoquinoline derivatives highlight his role as an influential inventor. His work continues to pave the way for advancements in treating various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile